PortfoliosLab logoPortfoliosLab logo
SMMT vs. STRL
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SMMT vs. STRL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Summit Therapeutics Inc. (SMMT) and Sterling Construction Company, Inc. (STRL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SMMT achieves a -19.33% return, which is significantly lower than STRL's 191.24% return. Over the past 10 years, SMMT has underperformed STRL with an annualized return of 4.15%, while STRL has yielded a comparatively higher 68.46% annualized return.


SMMT

1D
-4.47%
1M
-21.96%
YTD
-19.33%
6M
-24.24%
1Y
-31.47%
3Y*
100.52%
5Y*
13.84%
10Y*
4.15%

STRL

1D
1.07%
1M
5.57%
YTD
191.24%
6M
174.74%
1Y
332.96%
3Y*
155.47%
5Y*
104.86%
10Y*
68.46%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SMMT vs. STRL - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SMMT
Summit Therapeutics Inc.
-19.33%-1.99%583.72%-38.59%57.99%-42.77%193.75%39.13%-89.62%29.44%
STRL
Sterling Construction Company, Inc.
191.24%81.79%91.57%168.08%24.71%41.32%32.17%29.29%-33.11%92.43%

Correlation

The correlation between SMMT and STRL is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (5Y)
Calculated over the trailing 5-year period

0.20

Correlation (10Y)
Calculated over the trailing 10-year period

0.16

Correlation (All Time)
Calculated using the full available price history since Mar 5, 2015

0.14

Fundamentals

Market Cap

SMMT:

$10.94B

STRL:

$27.68B

EPS

SMMT:

-$1.60

STRL:

$11.19

PB Ratio

SMMT:

20.04

STRL:

23.27

Total Revenue (TTM)

SMMT:

$0.00

STRL:

$2.88B

Gross Profit (TTM)

SMMT:

-$83.36K

STRL:

$664.66M

EBITDA (TTM)

SMMT:

-$738.34M

STRL:

$429.99M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SMMT vs. STRL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SMMT
SMMT Risk / Return Rank: 2525
Overall Rank
SMMT Sharpe Ratio Rank: 2424
Sharpe Ratio Rank
SMMT Sortino Ratio Rank: 2828
Sortino Ratio Rank
SMMT Omega Ratio Rank: 2828
Omega Ratio Rank
SMMT Calmar Ratio Rank: 2121
Calmar Ratio Rank
SMMT Martin Ratio Rank: 2424
Martin Ratio Rank

STRL
STRL Risk / Return Rank: 9797
Overall Rank
STRL Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
STRL Sortino Ratio Rank: 9696
Sortino Ratio Rank
STRL Omega Ratio Rank: 9595
Omega Ratio Rank
STRL Calmar Ratio Rank: 9898
Calmar Ratio Rank
STRL Martin Ratio Rank: 9898
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SMMT vs. STRL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Summit Therapeutics Inc. (SMMT) and Sterling Construction Company, Inc. (STRL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SMMTSTRLDifference
Sharpe ratioReturn per unit of total volatility

-4.54

Sortino ratioReturn per unit of downside risk

-4.35

Omega ratioGain probability vs. loss probability

0.98

1.56

-0.58

Calmar ratioReturn relative to maximum drawdown

-0.60

10.82

-11.42

Martin ratioReturn relative to average drawdown

-0.92

30.19

-31.11

SMMT vs. STRL - Sharpe Ratio Comparison

The current SMMT Sharpe Ratio is -0.42, which is lower than the STRL Sharpe Ratio of 4.13. The chart below compares the historical Sharpe Ratios of SMMT and STRL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


SMMTSTRLDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.42

4.13

-4.54

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.08

1.85

-1.78

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.03

1.29

-1.26

Sharpe Ratio (All Time)

Calculated using the full available price history

0.02

0.27

-0.25

Drawdowns

SMMT vs. STRL - Drawdown Comparison

The maximum SMMT drawdown since its inception was -95.75%, roughly equal to the maximum STRL drawdown of -92.51%. Use the drawdown chart below to compare losses from any high point for SMMT and STRL.


Loading charts...

Drawdown Indicators


SMMTSTRLDifference

Max Drawdown

Largest peak-to-trough decline

-95.75%

-92.51%

-3.24%

Max Drawdown (1Y)

Largest decline over 1 year

-52.76%

-31.02%

-21.74%

Max Drawdown (3Y)

Largest decline over 3 years

-62.26%

-47.67%

-14.59%

Max Drawdown (5Y)

Largest decline over 5 years

-91.78%

-47.67%

-44.11%

Max Drawdown (10Y)

Largest decline over 10 years

-95.75%

-59.60%

-36.15%

Current Drawdown

Current decline from peak

-61.55%

-10.25%

-51.30%

Average Drawdown

Average peak-to-trough decline

-57.64%

-46.31%

-11.33%

Ulcer Index

Depth and duration of drawdowns from previous peaks

34.32%

11.09%

+23.23%

Volatility

SMMT vs. STRL - Volatility Comparison

The current volatility for Summit Therapeutics Inc. (SMMT) is 22.47%, while Sterling Construction Company, Inc. (STRL) has a volatility of 24.22%. This indicates that SMMT experiences smaller price fluctuations and is considered to be less risky than STRL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SMMTSTRLDifference

Volatility (1M)

Calculated over the trailing 1-month period

22.47%

24.22%

-1.75%

Volatility (6M)

Calculated over the trailing 6-month period

56.53%

63.81%

-7.28%

Volatility (1Y)

Calculated over the trailing 1-year period

75.95%

81.49%

-5.54%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

185.12%

56.99%

+128.13%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

144.63%

53.42%

+91.21%

Dividends

SMMT vs. STRL - Dividend Comparison

Neither SMMT nor STRL has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

SMMT vs. STRL - Financials Comparison

This section allows you to compare key financial metrics between Summit Therapeutics Inc. and Sterling Construction Company, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M202220232024202520260
825.68M
(SMMT) Total Revenue
(STRL) Total Revenue
Values in USD except per share items

Frequently Asked Questions


SMMT and STRL have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

STRL has higher volatility (24.22%) compared to SMMT (22.47%). In terms of maximum drawdown, SMMT dropped -95.75% vs STRL's -92.51%.

STRL currently has the higher Sharpe Ratio (4.13 vs -0.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SMMT and STRL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer